Dengue vaccine tetravalent (Sanofi Pasteur)

N/A

Report date: 2025/12/05 20:00:50

Base Information

Drug NameDengue vaccine tetravalent (Sanofi Pasteur)
Drug Alias NameTetravalent dengue vaccine,Live-attenuated-dengue serotype 1/2/3/4 virus vaccine,CYD dengue vaccine,ChimeriVax-DEN1-4,ChimeriVax-Dengue四价登革热疫苗 - 赛诺菲巴斯德Dengue vaccine tetravalent-SanofiLive, attenuated, dengue serotype 1, 2, 3, 4 virus vaccineDengue vaccine recombinant tetravalent-Sanofi +[14] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsYellow FeverDengue
Global Approved IndicationsDengue
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2018/12/12
Country/TerritoryUnited StatesVietnamSingapore +[16] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAcambisSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiSanofi Pasteur
Active IndicationsN/A
Inactive IndicationsYellow FeverDengue

Other Information

ATC CodeJ07BX
Related LinksN/A